ProKidney Corp. (PROK)
NASDAQ: PROK
· Real-Time Price · USD
3.04
-0.13 (-4.10%)
At close: Oct 16, 2025, 3:59 PM
3.00
-1.30%
After-hours: Oct 16, 2025, 07:44 PM EDT
-4.10% (1D)
| Bid | 2.98 |
| Market Cap | 908.95M |
| Revenue (ttm) | 527K |
| Net Income (ttm) | -72.47M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -5.43 |
| Forward PE | -5.94 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 3.25 |
| Volume | 1,479,739 |
| Avg. Volume (20D) | 2,951,452.1 |
| Open | 3.20 |
| Previous Close | 3.17 |
| Day's Range | 2.99 - 3.28 |
| 52-Week Range | 0.46 - 7.13 |
| Beta | 1.77 |
| Ex-Dividend Date | n/a |
About PROK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PROK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PROK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsProKidney Corp. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-8.67%
PROK stock has given up its prior gain. ProKidney ...
Unlock content with
Pro Subscription
3 months ago
-8.67%
ProKidney shares are trading higher after the company announced it is aligned with the FDA regarding the accelerated approval and pathway for Rilparencel.
